Product Information
EXEMESTANE 25 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.6119 per EA under NDC 69097031602. Its NADAC has been published 413 times since Aug 1, 2018.
Strength
25 mg/1
Manufacturer
Cipla USA Inc.NDC
69097031602
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
EXEMESTANEApproval Type
Generic (ANDA)
FDA Application
ANDA210323On Market Since
4/27/2018
Pharmacological Classes
Price Statistics
The NADAC for EXEMESTANE 25 MG TABLET has been published 413 times since Aug 1, 2018, and over the history we have for it it has declined 84.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6119 per EA |
|---|---|
| All-time high | $3.8368 (Aug 15, 2018) |
| All-time low | $0.5602 (Jul 17, 2024) |
| 52-week high | $0.8721 |
| 52-week low | $0.5751 |
| Median price | $1.1669 |
| Average price | $1.4777 |
| Largest weekly change | +39.9% (Jan 18, 2023) |
| Weeks tracked | 413 |
| Tracking since | Aug 1, 2018 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EXEMESTANE 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EXEMESTANE 25 MG TABLET, manufactured by Cipla USA Inc., is $0.6119 per EA (NDC 69097031602), effective Jun 24, 2026.
How has the price of EXEMESTANE 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for EXEMESTANE 25 MG TABLET has declined 84.1%. It has been tracked across 413 weekly CMS publications since Aug 1, 2018.
What are the highest and lowest recorded NADAC prices for EXEMESTANE 25 MG TABLET?
Since Aug 1, 2018, the NADAC for EXEMESTANE 25 MG TABLET has ranged from a low of $0.5602 (Jul 17, 2024) to a high of $3.8368 (Aug 15, 2018), with a median of $1.1669 per EA.
Are there cheaper alternatives to EXEMESTANE 25 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as EXEMESTANE 25 MG TABLET, but none are currently priced below it.
Who manufactures EXEMESTANE 25 MG TABLET?
EXEMESTANE 25 MG TABLET (NDC 69097031602) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification